Consensus Bruker Corporation

Equities

BRKR

US1167941087

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 04:00:00 2025-12-15 pm EST			5-day change	1st Jan Change
45.67 ^USD	+1.20%		-0.72%	-22.09%

Dec. 15	Bruker Corporation Presents at 7th Annual Wolfe Research Healthcare Conference, Nov-17-2025 04:00 PM
Dec. 10	Wolfe Research Upgrades Bruker to Outperform From Peer Perform, $60 Price Target	MT

Evolution of the Average Target: Bruker Corporation

Evolution of the Target Price: Bruker Corporation

Changes in Analyst Recommendations: Bruker Corporation

3c039a1f56f9e3b31881.M3Xlipr-ePZaskeqGl7PvNvVCQqH0lNeSH2iWeWqkNQ.ViPI86-9L84L6zfCaDCI1K2ae0LhuQY1KRXLFd3noI5gPdKn_LcvpgDjdw~aa45679c9a84c6293edabab2c48f01fd

Analysts' recommendations: Bruker Corporation

Dec. 10	Wolfe Research Upgrades Bruker to Outperform From Peer Perform, $60 Price Target	MT
Nov. 20	Rothschild & Co Redburn Initiates Coverage on Bruker With Buy Rating, $60 Price Target	MT
Nov. 04	UBS Adjusts Price Target on Bruker to $43 From $40, Maintains Neutral Rating	MT
Nov. 04	Analysts recommendations: Apple, Comcast, Crocs, Eli Lilly, Palantir…
Nov. 03	(BRKR) Bruker Expects 2025 Non-GAAP EPS Range $1.85 to $1.90, vs. FactSet Est of $1.93	MT
Nov. 02	Certain Restricted Stock Units of Bruker Corporation are subject to a Lock-Up Agreement Ending on 3-NOV-2025.	CI
May. 22	Citigroup Downgrades Bruker to Neutral From Buy, Lowers Price Target to $40 From $50	MT
May. 08	UBS Cuts Price Target on Bruker to $45 From $57, Keeps Neutral Rating	MT
Apr. 14	BofA Securities Lowers Bruker Price Target to $61 From $76	MT
Feb. 14	The glass is always half full
Feb. 14	Analyst recommendations: Bunzl, Bellway, Shell, Coinbase, Spotify…
Feb. 14	Analyst recommendations: Airbnb, Datadog, Avis, Coinbase, Roku...
Dec. 19	Guggenheim Initiates Coverage on Bruker With Buy Rating, $72 Price Target	MT
Dec. 10	UBS Downgrades Bruker to Neutral From Buy, Cuts Price Target to $66 From $102	MT
Dec. 05	Goldman Sachs Upgrades Bruker to Neutral From Sell, Price Target is $60	MT
24-09-30	Wolfe Research Downgrades Bruker to Peer Perform From Outperform	MT
24-07-09	Goldman Sachs Adjusts Price Target on Bruker to $60 From $72, Maintains Sell Rating	MT
24-05-20	Stifel Adjusts Price Target on Bruker to $77 From $81, Maintains Hold Rating	MT
24-04-10	Goldman Sachs Raises Price Target on Bruker to $74 From $66, Maintains Sell Rating	MT
24-03-01	UBS Raises Bruker Price Target to $102 From $94, Maintains Buy Rating	MT
24-02-15	UBS Adjusts Bruker Price Target to $94 From $86, Maintains Buy Rating	MT
24-02-14	TD Cowen Adjusts Bruker's Price Target to $84 From $75, Keeps Market Perform Rating	MT
24-02-14	Stifel Adjusts Bruker's Price Target to $81 From $63, Keeps Hold Rating	MT
24-02-14	Leerink Partners Adjusts Bruker's Price Target to $90 From $86, Keeps Outperform Rating	MT
24-02-14	Citigroup Adjusts Bruker's Price Target to $95 From $80, Keeps Buy Rating	MT

More recommendations

Sector Comparison:

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	BRUKER CORPORATION					+8.58%
	THERMO FISHER SCIENTIFIC, INC.					+10.42%
	INTUITIVE SURGICAL, INC.					+9.87%
	DANAHER CORPORATION					+13.15%
	BOSTON SCIENTIFIC CORPORATION					+36.62%
	SIEMENS HEALTHINEERS AG					+29.43%
	EDWARDS LIFESCIENCES CORPORATION					+15.01%
	AGILENT TECHNOLOGIES, INC.					+21.3%
	GE HEALTHCARE TECHNOLOGIES INC.					+5.77%
	RESMED, INC.					+16.59%
	Average					+16.67%
	Weighted average by Cap.					+16.55%

See all sector consensus

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

45.67USD

Average target price

51.29USD

Spread / Average Target

+12.30%

High Price Target

75.00USD

Spread / Highest target

+64.22%

Low Price Target

40.00USD

Spread / Lowest Target

-12.42%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Wolfe Research
Rothschild & Co Redburn
UBS
Citigroup
BofA Securities
Guggenheim
Goldman Sachs
Stifel Nicolaus
JPMorgan Chase
Jefferies & Co.
Leerink Partners
TD Cowen
SVB Leerink
Wells Fargo Securities
Cleveland Research